|
advertisement
|
|
|
| Journal Articles Details
|
|
More October, 2004 pharmacogenomics journal articles.- Clinical and functional consequences of platelet membrane glycoprotein polymorphisms.
by Yee DL, Bray PF.
Journal: Semin Thromb Hemost. 30(5):591-600
- Pharmacogenomics of adrenoceptors.
by Flordellis C, Paris H, Karabinis A, Lymperopoulos A.
Journal: Pharmacogenomics. 5(7):803-17
- Toward the pharmacogenomics of cystic fibrosis - an update.
by Sangiuolo F, D'Apice MR, Gambardella S, Di Daniele N, Novelli G.
Journal: Pharmacogenomics. 5(7):861-78
- Genetic testing in primary care.
by Burke W.
Journal: Annu Rev Genomics Hum Genet. 5:1-14
- Microarrays in pharmacogenomics.
by Chen JJ.
Journal: J Biopharm Stat. 14(3):535-7
- Pharmacogenetics in the rheumatic diseases.
by Cronstein BN.
Journal: Ann Rheum Dis. 63 Suppl 2:ii25-ii27
- How molecular medicine transforms policy (and everything else).
by Kean MA, Batchelder KF.
Journal: J Biolaw Bus. 7(3):16-9
- Will tomorrow's medicines work for everyone?
by Tate SK, Goldstein DB.
Journal: Nat Genet. 36(11 Suppl):S34-42
- The wild genetic goose chase: Neil Holtzman talks about genetics and medicine [interview by Brandon Keim].
by Holtzman N.
Journal: Genewatch. 2004 Jul-Aug;17(4):6-10
- Optimized antiretroviral therapy: the role of therapeutic drug monitoring and pharmacogenomics.
by van Heeswijk RP.
Journal: Expert Rev Anti Infect Ther. 1(1):75-81
- Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.
by Redon J, Luque-Otero M, Martell N, Chaves FJ.
Journal: Pharmacogenomics J. 10 2004;:
- Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
by Liljedahl U, Lind L, Kurland L, Berglund L, Kahan T, Syvänen AC.
Journal: BMC Cardiovasc Disord. 09 2004;4(1):16
- Genetic determinants of platelet function in thromboembolic diseases.
by Corral J, González-Conejero R, Vicente V.
Journal: J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):166-71
- Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.
by Clark JJ, Cools J, Curley DP, Yu JC, Lokker NA, Giese NA, Gilliland DG.
Journal: Blood. 104(9):2867-72
- [Adjuvant therapy for colon cancer]
by Lordick F, Rosenberg R, Stein HJ, Peschel C, Siewert JR.
Journal: Dtsch Med Wochenschr. 129(44):2366-71
- Genetic association studies in epilepsy: "the truth is out there".
by Tan NC, Mulley JC, Berkovic SF.
Journal: Epilepsia. 45(11):1429-42
- Jonathan K. C. Knowles discusses the impact of pharmacogenomics on market segmentation.
by Knowles JK.
Journal: Nat Rev Drug Discov. 3(10):822
- Human genetic banking: altruism, benefit and consent.
by Williams G, Schroeder D.
Journal: New Genet Soc. 23(1):89-103
- Pharmacogenetics of methotrexate.
by Krajinovic M, Moghrabi A.
Journal: Pharmacogenomics. 5(7):819-34
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|